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ABSTRAK ABSTRACT
Tujuan: mengidentifikasi efektivitas terapi Rat Bone Marrow
stem sel pada tikus model PCOS terhadap folikulogenesis,
ekspresi TGF- dan GDF-9 serta terhadap kadar estrogen, TNF-
dan androgen.
Bahan dan Metode: Penelitian ini merupakan penelitian eksperi-
mental laboratorium menggunakan hewan coba. SOPK diinduksi
dengan pemberian hormone testosterone provionat, pada 30 ekor
tikus. Subjek penelitian dibagi menjadi 2 kelompok: kontrol dan
perlakuan diberi sel punca. Penyuntikan sel punca dilakukan pada
tikus perlakuan, kemudian dilakukan pemeriksaan dengan swab
vagina. Pemeriksaan TNF- dengan menggunakan imunohisto-
kimia dan pemeriksaan kadar androgen dengan menggunakan
ELISA. Data dibandingkan dengan student t-test.
Hasil: jumlah rerata ekspresi TNFα pada kelompok perlakuan
lebih rendah dibandingkan dengan kelompok perlakuan (kontrol
5,35 vs perlakuan 2,34, Sig 0,0026). Jumlah rerata kadar androgen
pada perlakuan lebih rendah dibandingkan dengan rerata apda
kontrol (kontrol 2,31 VS perlakuan 0,40, Sig 0,0026).
Simpulan: pada percobaan tikus SOPK,sel punca menurunkan
ekspresi TNFα dan kadar androgen.
Kata kunci: sel punca, SOPK, TNFα, kadar androgen
Objectives: to identify therapeutic effectiveness of Rat Bone
Marrow stem cell in PCOS rats model on folliculogenesis, TGF-
beta and GDF-9 expression and on estrogen, TNF- and androgen
levels.
Material and Methods: this study is a laboratory experimental
research with using animal testing. PCOS was induced by the
administration of testosterone propionate hormone into 30 mice.
The subjects of this study are divided into 2 groups: stem cell
group and control group. The mice were injected with testosterone
then vaginal swab was performed to determine the mice cycle.
After determining mice in anestrous cycle, stem cell was injected.
TNF- was measured with immunohistochemistry and androgen
was examined using ELISA. The data was measured by student t-
test.
Result: The average number of TNF- expression in control
group was lower than stem cell group (5.35 vs 2.34; p= 0.0026).
The average androgen level for stem cell group was lower than
mean for control group (2.31 vs 0.40; p= 0.0026).
Conclusion: In this study of polycystic model mice, stem cell
decreased the expression of TNF- and androgen level
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INTRODUCTION
Poly Cystic Ovarian Syndrome (PCOS) is the most
common endocrine disorder in women within their
reproductive age with a prevalence of 4-12%. PCOS
itself is a heterogeneous problem with extremely com-
plex symptoms (Sheehan, 2004)
Stem cells have the ability to differentiate into other
cells and develop into various types of mature cells.
Furthermore, stem cell is able to regenerate itself or
make a copy of cells identical to themselves through
cell division (Saputra, 2006). Bone Marrow Stem
Cell therapy is used as a carrier of transgene or cells
into the body because these stem cells have the ability to
express a gene or a specific cell in the body. Bone
Marrow Stem Cell has the properties of self-renewing,
so that the administration of therapy does not need to be
repeated. In addition, the characteristic of hematopoietic
stem cells is also able to differentiate into other types of
cells, so the cells can settle in various types of cells and
repairing damaged cells through cell division process
(Fungi et al., 2001).
In the case of PCOS, Tumor Necrosis Factor α plays an
important role in the process insulin resistance. The
discovery of TNF α in adipose tissue, especially in
obese patients, proves that TNF-α plays an important
role in the pathogenesis of PCOS.(Samy., 2009)
Therefore Bone Marrow Stem Cell therapy for PCOS
needs to be reviewed in biomolecular reproduction field
to reveal the mechanism of folliculogenesis and egg cell
maturation as an evidence basis for scientific stu-
dy. This study is using rats as animal model of PCOS
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solely because of ethical factors and to make the
research easier.
MATERIAL AND METHODS
This study is an experimental laboratory research with
double blind randomized design. The population in this
study is mice (Mus musculus) from animal unit labora-
tory. To create the mice model of PCOS, testoste-rone
propionate were injected with a dose of 100 mg/kgbw
for 14 days. After that vaginal swab exam-ination was
performed to determine the estrous cycle of mice, on
day 15. In mice with PCOS, on the 15th day the vaginal
swab will appear as diestrous phase. Vaginal swab was
performed in PCOS mice model by inserting wet cotton
into the vagina and twisting it around, then it was
applied to the object glass. After that, it was fixed with
70% alcohol for 5 minutes. The Giemsa dye was
dripped on the object glass for 2-3 minutes, then it was
washed with water and dried. Then it was examined
under microscope to determine the stage of estrous
cycle including proestrous, estrous, metestrous and
diestrous.
Mouse’s bone marrow was isolated. MEM medium was
added and then centrifuged at 3000 rpm for 10 minutes
and was repeated up to 2 times. The precipitate was
then cultured in MEM medium and added with
antibiotic, anti-fungal and 15% Fetal Calf Serum (FCS).
Pasese performed repeatedly until a cell line was
formed. PCOS mice models were treated with Rat Bone
Marrow Stem Cell cultures derived from rat bone
marrow conducted in Tropical Disease Research Centre,
University of Airlangga. Injections were given in a
single dose at a dose of 10 6/mouse. Intravenous inject-
tions were injected on the tail. Before injections, the tail
was warmed therefore there the tail’s blood vessel was
dilated. PCOS rat model’s vagina was swabbed after
Rat Bone Marrow Stem Cell therapy, a wet cotton was
inserted in the vagina and twisted around, then applied
to the object glas. Then it was fixed with 70% alcohol
for 5 minutes. Then object glass was dripped with
Giemsa dye, it was for 2-3 minutes, then washed with
water and dried subsequently examined under
microscope to determine the stage of the estrous cycle
such as proestrous, estrous, metestrous and diestrous.
Ovarian tissues were fixed on an object glass,
paraffinization, deparaffinization and coating process
with a secondary antibody were then performed. After
that TNF Alpha monoclonal antibody was washed and
coated to determine the location of the hyaluronan
receptor. Counterstaining used was commasie blue
Immunohistochemistry method used is the avidin -
biotin model and antibodies. Ovarium tissue was taken
and serially selected to get the number of follicles and
its morphology. In situ hybridization (ISH) was conduc-
ted to determine the location of the tissue and 17 α-
hydroxylase (17 α-OH) mRNA level. Then ELISA
examination was performed.
This research was conducted in 2014 in In Vitro
Fertilization Laboratory of the Faculty of Veterinary
Medicine Airlangga University. Ethical eligibility of
this study was approved by the Ethics Committee of the
Faculty of Veterinary Medicine, Airlangga University
Surabaya
RESULT AND DISCUSSION
PCOS modeling was done by injection of testosterone
propionate in female mice with 100 mg / kg dose for 14
days. On day 15, the mice’s vagina was swabbed to
observe the estrous cycle after being injected with tes-
tosterone propionate. Vaginal swab test results of all the
mice were in diestrous phase. Data of the vaginal swab
results were presented in Table 1.
Table 1. Percentage of estrous cycle in PCOS rat model
before and after RBMSC therapy
Group Sexual arousal cycle
Proestrous Estrous Metestrous Diestrous
Control 0 (0%) 0 (0%) 0 (0%) 15 (100%)
RBMSC
treatment
8 (53.4%) 4 (26.4%) 0 (0%) 3 (20%)
After the PCOS animal models were treated with Rat
Bone marrow Stem Cell with dose of 1x106/mouse and
the reproductive cycle was examined, the results were
that all of the control group who did not receive
Rat Bone Marrow Stem Cell therapy 100% were on
diestrous phase. The treatment group were treated
Rat Bone Marrow Stem Cell, the reproductive cycle of
most animals turn into a model of PCOS proestrus
phase (53.4%) and estrus (26.4%), although a small
portion remains in the diestrus phase of (20%). This
shows that the administration of Bone Marrow Stem
Cell therapy can improve the reproductive cycle. Data
from the vaginal swab of PCOS animal models after
treatment with Rat Bone Marrow Stem Cell was
presented in Table 1 above.
Folliculogenesis examination results with Haematoxillin
eosin staining of PCOS rat model’s ovarium can be seen
in Table 2.
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Table 2. Data of the development of follicles in the ovaries of PCOS Model Rats after
treated with Rat Bone Marrow Stem Cell
Group
(X ± SD)
Primary
follicle
Secondary
follicle
Tertiary
follicle
Follicles De
Graff
Control 1.93 ± 1.03 a 1.80 ± 1.45 a 0.93 ± 0.59 a 0.07 ± 0.02 a
Treatment 2.80 ± 1.01 b 2.87 ± 1.59 b 3.40 ± 1.84 b 1.07 ± 0.07 b
Description: different superscript in the same column shows the significant differences
Statistical analysis of the results showed that the rat
model of PCOS after getting Rat Bone Marrow Stem
Cell was significantly different compared with the
control group of PCOS mice model that was not treated
with Bone Marrow Stem Cell.
Expression of Tumor Necrosis Alpha in each sample
was assessed semiquantitatively according to the
modified method Remmele (Novak et al., 2007). Index
scale Remmele (IRS) is the multiplication of immuno-
reactive cell expressing TNF-α percentages score to the
intensity of the color produced on the cell score
(Appendix 1). The effect of Rat Bone Marrow Stem
Cell therapy in PCOS mice models through immu-
nohistochemistry staining, counted semiquantitatively,
can be seen in Table 3.
From the analysis of calculations performed with
Kruskal Wallis test to the overall treatment, the results
obtained were significantly different (p <0.05). If the
result of the analysis was significantly different then
the non-parametric test comparison Mann-Whitney test
was performed to show the significant differences
between 2 treatments (p <0.05), it meant that there was
a difference between control and treatment groups in the
expression of T NF-α in the ovary.
Table 3. Mean of the expression of TGF-β in PCOS Rat
Model’s ovaries after treatment with Rat Bone
Marrow Stem Cel
Mean value Sig
Control Treatment
5.35 2.34 0.0026 *
On the Mann-Whitney test control and treatment groups
had a significant difference. This indicated that between
control and treatment groups the expression of TNF-
α were different and the treatment gave a noticeable
effect. It appeared also on the average results of the
expression of TNF-α, it showed that the average differ-
ence in expression of TNF-α in treatment group was
greater (2.34) than control.
Androgen levels in each sample assessed semi-
quantitatively according to the modified method
Remmele (Novak et al., 2007 Index scale Remmele
(IRS) is the multiplication of immunoreactive cell
expressing TNF-α percentages score to the intensity of
the color produced on the cell score (Appendix 1). The
effect of Rat Bone Marrow Stem Cell therapy in PCOS
mice models through immunohistochemistry staining,
counted semiquantitatively, can be seen in Table 3
From the analysis of calculations performed with
Kruskal Wallis to the overall treatment, the results
obtained are significantly different (p <0.05). ). If the
result of the analysis was significantly different then
the non-parametric test comparison Mann-Whitney test
was performed to show the significant differences
between 2 treatments (p <0.05), it meant that there was
a difference between control and treatment groups in the
expression of androgen levels in the ovary.
Table 4. The mean value of ELISA Androgens in PCOS
Rat Model’s ovaries after treatment
with Rat Bone Marrow Stem Cell
Mean value Sig
Control Treatment
2.31 0.40 0.0026 *
Mann-Whitney test between control and treatment
groups had significant differences. This indicated that
between control and treatment groups there were
different androgen ELISA mean value and the treatment
gave a noticeable effect. It appeared also on the average
results of androgen ELISA, it showed that the
average difference of androgen ELISA in treatment
group was greater (2.34) than control.
CONCLUSION
As the study ended it can be concluded that the stem
cells in PCOS will improve folliculogenesis and im-
provement of inflammatory mediators TNF α and
improved levels of androgen.
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